Solesence, Inc., a science-driven company, develops, manufactures, and sells integrated family of technologies in the United States. The company is headquartered in Romeoville, Illinois.
| Revenue (TTM) | $55.37M |
| Gross Profit (TTM) | $13.86M |
| EBITDA | -921,000 |
| Operating Margin | 0.79% |
| Return on Equity | -18.50% |
| Return on Assets | -2.35% |
| Revenue/Share (TTM) | $0.78 |
| Book Value | $0.19 |
| Price-to-Book | 4.57 |
| Price-to-Sales (TTM) | 1.08 |
| EV/Revenue | 1.476 |
| EV/EBITDA | 27.69 |
| Quarterly Earnings Growth (YoY) | -93.50% |
| Quarterly Revenue Growth (YoY) | -24.70% |
| Shares Outstanding | $70.65M |
| Float | $18.33M |
| % Insiders | 73.09% |
| % Institutions | 5.45% |
Volatility is currently contracting
Solesence's Q2 results are pressured by higher operating expenses, but improving production efficiency and expectations for a stronger second half provide reasons for optimism.
Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript
Please call Alissa Nakamoto at 216-509-9062 to confirm the details of the release. Please ensure that the release has the same distributions as past PRs.
ROMEOVILLE, Ill., July 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the second quarter of 2026 before the market opens on Tuesday, August 11, 2026, and host a conference call and webcast on the same date.
Solesence expands its scalp care portfolio with a barrier-repair serum and SPF 45+ dry shampoo powered by patented technologies for hydration, oil control and UV protection.
New White Label Collection, Powered by WHSPR™ and Kleair™, Debuts with Revitalizing Scalp Serum and Scalp Screen Dry Shampoo SPF 45+ Sunscreen
Global Award Recognizes Excellence in Service, Reliability, and Innovation ROMEOVILLE, Ill., June 18, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc.
SPF-Infused Concealer Featuring Kleair™, WHSPR™, and Chromalüm™ Recognized Across Anti-Aging, Color Cosmetics, and Compromised Skin
Solesence incurs a Q1 loss per share as shipment delays pressure revenues, even as gross margin improves and the company reaffirms its 2026 profitability targets.
Solesence, Inc. (SLSN) Q1 2026 Earnings Call Transcript
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SLSN and any ticker you trade — then tracks every position and per-strategy win rate.
